The RayPlex Infliximab (Remicade®) DA kit is a cytometric bead assay to quantitatively measure Infliximab (Remicade®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.
The RayPlex Infliximab (Remicade®) DA kit is a cytometric bead assay to quantitatively measure Infliximab (Remicade®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.
The RayPlex Nivolumab (Opdivo®) DA kit is a cytometric bead assay to quantitatively measure Nivolumab (Opdivo®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.
The RayPlex Panitumumab (Vectibix®) DA kit is a cytometric bead assay to quantitatively measure Panitumumab (Vectibix®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.
The RayPlex Panitumumab (Vectibix®) DA kit is a cytometric bead assay to quantitatively measure Panitumumab (Vectibix®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.
The RayPlex Pembrolizumab (Keytruda®) DA kit is a cytometric bead assay to quantitatively measure Pembrolizumab (Keytruda®) antibodies by flow cytometry. The assay has been optimized for serum and plasma.
